These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19273112)

  • 1. Targeting of G protein-coupled receptors to the plasma membrane in health and disease.
    Ulloa-Aguirre A; Conn PM
    Front Biosci (Landmark Ed); 2009 Jan; 14(3):973-94. PubMed ID: 19273112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.
    Ulloa-Aguirre A; Michael Conn P
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):13-24. PubMed ID: 22074574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.
    Ulloa-Aguirre A; Zariñán T; Jardón-Valadez E
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.
    Maya-Núñez G; Ulloa-Aguirre A; Janovick JA; Conn PM
    Subcell Biochem; 2012; 63():263-89. PubMed ID: 23161143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of G protein-coupled receptor export trafficking.
    Dong C; Filipeanu CM; Duvernay MT; Wu G
    Biochim Biophys Acta; 2007 Apr; 1768(4):853-70. PubMed ID: 17074298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases.
    Ulloa-Aguirre A; Zariñán T; Gutiérrez-Sagal R; Tao YX
    Front Endocrinol (Lausanne); 2022; 13():934685. PubMed ID: 36093106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of post-Golgi traffic of G protein-coupled receptors.
    Wu G
    Subcell Biochem; 2012; 63():83-95. PubMed ID: 23161134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An escort for GPCRs: implications for regulation of receptor density at the cell surface.
    Achour L; Labbé-Jullié C; Scott MG; Marullo S
    Trends Pharmacol Sci; 2008 Oct; 29(10):528-35. PubMed ID: 18760490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPCR oligomerization: contribution to receptor biogenesis.
    Van Craenenbroeck K
    Subcell Biochem; 2012; 63():43-65. PubMed ID: 23161132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
    Ulloa-Aguirre A; Janovick JA; Brothers SP; Conn PM
    Traffic; 2004 Nov; 5(11):821-37. PubMed ID: 15479448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein-coupled receptor trafficking: understanding the chemical basis of health and disease.
    Ulloa-Aguirre A; Janovick JA; Miranda AL; Conn PM
    ACS Chem Biol; 2006 Nov; 1(10):631-8. PubMed ID: 17168568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.
    Conn PM; Ulloa-Aguirre A
    Trends Endocrinol Metab; 2010 Mar; 21(3):190-7. PubMed ID: 20005736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A membrane-proximal, C-terminal α-helix is required for plasma membrane localization and function of the G Protein-coupled receptor (GPCR) TGR5.
    Spomer L; Gertzen CG; Schmitz B; Häussinger D; Gohlke H; Keitel V
    J Biol Chem; 2014 Feb; 289(6):3689-702. PubMed ID: 24338481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting opioid receptors with pharmacological chaperones.
    Petäjä-Repo UE; Lackman JJ
    Pharmacol Res; 2014 May; 83():52-62. PubMed ID: 24355364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal Signal Peptides of G Protein-Coupled Receptors: Significance for Receptor Biosynthesis, Trafficking, and Signal Transduction.
    Rutz C; Klein W; Schülein R
    Prog Mol Biol Transl Sci; 2015; 132():267-87. PubMed ID: 26055063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological chaperone action on G-protein-coupled receptors.
    Bernier V; Bichet DG; Bouvier M
    Curr Opin Pharmacol; 2004 Oct; 4(5):528-33. PubMed ID: 15351360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular chaperones and G protein-coupled receptor maturation and pharmacology.
    Tao YX
    Mol Cell Endocrinol; 2020 Jul; 511():110862. PubMed ID: 32389798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.
    Hou ZS; Ulloa-Aguirre A; Tao YX
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants regulating cell surface targeting of melanocortin receptors.
    Rodrigues AR; Sousa D; Almeida H; Gouveia AM
    J Mol Endocrinol; 2013 Oct; 51(2):R23-32. PubMed ID: 23907004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.